Skip to main content
Figure 5 | Breast Cancer Research

Figure 5

From: ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma

Figure 5

Association of ARTEMIN (ARTN) and TWIST1 expression with survival outcome in estrogen receptor (ER) negative mammary carcinoma (ER-MC). (a) ARTN and TWIST1 expression detected by immunohistochemistry (IHC) in ER-MC samples. ARTN is predominantly localised to the cytoplasm whereas TWIST1 predominantly localized to the nucleus. 200× magnification. (b) Kaplan-Meier analysis of the association of ARTN expression (i), TWIST1 expression (ii), low-ARTN and low-TWIST1 vs high ARTN expression and low-TWIST1expression (iii) and low-ARTN and low-TWIST1 vs high ARTN and high TWIST1 expression (iv); relapse free survival (RFS) in ER-MC patients.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us